Related Experiment Video
Updated: Feb 9, 2026

Preparation of Segmented Microtubules to Study Motions Driven by the Disassembling Microtubule Ends
Published on: March 15, 2014
Molecular basis of resistance to the microtubule-depolymerizing antitumor compound plocabulin
Areti Pantazopoulou1,2, Carlos María Galmarini3, Miguel A Peñalva4
1Department of Cellular and Molecular Biology, Centro de Investigaciones Biológicas, CSIC, Madrid, Spain. apantazopoulou@uchicago.edu.
Abstract:
Plocabulin (PM060184) is a microtubule depolymerizing agent with potent antiproliferative activity undergoing phase II clinical trials for the treatment of solid tumors. Plocabulin shows antifungal activity virtually abolishing growth of the filamentous fungus Aspergillus nidulans. A. nidulans hyphae depend both on mitotic and interphase microtubules, as human cells. Here, we exploited the A. nidulans genetic amenability to gain insight into the mechanism of action of plocabulin. By combining mutations in the two A. nidulans β-tubulin isotypes we obtained a plocabulin-insensitive strain, showing that β-tubulin is the only molecular target of plocabulin in fungal cells. From a genetic screen, we recovered five mutants that show plocabulin resistance but do not carry mutations in β-tubulin. Resistance mutations resulted in amino acid substitutions in (1) two subunits of the eukaryotic translation initiation factor eIF2B activating the General Amino Acid Control, (2) TIM44, an essential component of the inner mitochondrial membrane translocase, (3) two transcription factors of the binuclear zinc cluster family potentially interfering with the uptake or efflux of plocabulin. Given the conservation of some of the identified proteins and their respective cellular functions in the tumor environment, our results pinpoint candidates to be tested as potential biomarkers for determination of drug efficiency.
Insights
Plocabulin targets fungal beta-tubulin, but resistance can arise from mutations affecting protein synthesis and mitochondrial function. These findings suggest potential biomarkers for plocabulin drug efficacy in cancer treatment.
Area of Science:
- Microbiology
- Molecular Biology
- Pharmacology
Background:
- Plocabulin (PM060184) is a microtubule depolymerizing agent with demonstrated antiproliferative activity in solid tumors.
- The drug exhibits potent antifungal activity against Aspergillus nidulans, highlighting conserved cellular targets.
- Understanding plocabulin's mechanism in fungi can provide insights into its action in human cells and potential resistance pathways.
Purpose of the Study:
- To elucidate the molecular mechanism of action and identify resistance factors for plocabulin using the genetically tractable fungus Aspergillus nidulans.
- To investigate the role of beta-tubulin as the primary target of plocabulin.
- To identify novel cellular pathways and proteins involved in plocabulin sensitivity and resistance.
Main Methods:
- Genetic analysis of plocabulin resistance in Aspergillus nidulans.
- Construction of a plocabulin-insensitive strain by combining mutations in beta-tubulin isotypes.
- Functional screening of resistant mutants to identify genes conferring resistance.
- Identification of mutations in eukaryotic translation initiation factor eIF2B, TIM44, and transcription factors.
Main Results:
- Confirmation that fungal beta-tubulin is the sole molecular target of plocabulin.
- Identification of five plocabulin-resistant mutants lacking beta-tubulin mutations.
- Resistance mutations were found in subunits of eIF2B (General Amino Acid Control), TIM44 (mitochondrial translocase), and binuclear zinc cluster transcription factors.
- These proteins are involved in translation initiation, mitochondrial function, and potentially drug transport.
Conclusions:
- Fungal beta-tubulin is the essential target of plocabulin.
- Novel resistance mechanisms involve pathways regulating protein synthesis, mitochondrial function, and drug transport.
- Conserved proteins identified in resistance pathways may serve as biomarkers for plocabulin efficacy in cancer therapy.
More Related Videos
Related Concept Videos
Molecular Compounds: Formulas and Nomenclature
Microtubules
Microtubules
Microtubules have two structurally similar globular protein subunits: α and β tubulins. In the cytosol, the α and β tubulins form a heterodimer....
Lewis Structures of Molecular Compounds and Polyatomic Ions
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Molecules and Compounds

